4 employees
Neurocycle Therapeutics is a biopharmaceutical company that focuses on sub-type selective GABA-A modulation.
2017
$11K
from 1 investors over 1 rounds
NeuroCycle Therapeutics raised $11K on July 7, 2015
Investors: Venture Kick